Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome concomitant with systemic sclerosis, immune thrombocytopenic purpura

Internal Medicine

Volumn 48, Issue 23, 2009, Pages 2019-2023

  Toyoda, Megumi ^a   Yokomori, Hiroaki ^a   Kaneko, Fumihiko ^a   Yoshida, Hide ^a   Hoshi, Kenta ^a   Takeuchi, Hajime ^a   Tahara, Kumiko ^a   Takahashi, Akihiko ^a   Kudo, Takeo ^a   Motoori, Tadashi ^a   Ohbu, Makoto ^a   Kondo, Hirobumi ^a   Hibi, Toshifumi ^b  

^a KITASATO UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Autoimmune; Hepatitis (AIH); Immune thrombocytopenic purpura (ITP); Primary biliary cirrhosis (PBC); Systemic sclerosis (SSc)

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMINOTRANSFERASE; AMOXICILLIN; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CLARITHROMYCIN; CREATININE; DOUBLE STRANDED DNA ANTIBODY; GUANOSINE TRIPHOSPHATE; HLA DR4 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LANSOPRAZOLE; MITOCHONDRION ANTIBODY; PREDNISOLONE; RHEUMATOID FACTOR; UREA; URSODEOXYCHOLIC ACID;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BARRETT ESOPHAGUS; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHOLANGITIS; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; ELECTROCARDIOGRAM; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FIBERSCOPE ENDOSCOPY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LIVER BIOPSY; LIVER DYSFUNCTION; PRIMARY BILIARY CIRRHOSIS; RAYNAUD PHENOMENON; STOMACH DISEASE; STOMACH HEMORRHAGE; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY; UREA NITROGEN BLOOD LEVEL;

FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER CIRRHOSIS, BILIARY; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SCLERODERMA, SYSTEMIC;

EID: 73449115663     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.2687     Document Type: Article

References (33)

1. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 353: 1261-1273, 2005.
2. Watt FE, James OF, Jones DE. Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a populationbased cohort study. QJM 97: 397-406, 2004.
3. West M, Jasin HE, Medhekar S. The development of connective tissue diseases in patients with autoimmune hepatitis: a case series. Semin Arthritis Rheum 35: 344-348, 2006.
4. Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med 125: 588-598, 1996.
5. Poupon R. Autoimmune overlapping syndromes. Clin Liver Dis 7: 865-878, 2003.
6. Woodward J, Neuberger J. Autoimmune overlap syndromes. Hepatology 33: 994-1002, 2001.
7. Lohse AW, zum Buschenfelde KH, Franz B, Kanzler S, Gerken G, Dienes HP. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology 29: 1078-1084, 1999.
8. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23: 581-590, 1980.
9. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15: 202-205, 1988.
10. Ohta Y. Diagnostic criteria for primary biliary cirrhosis. Acta Hepatol Jpn 33: 657, 1992 (in Japanese).
11. Ichida F, Tsuji T, Omata M, et al. New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun 6: 112-111, 1996.
12. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31: 929-938, 1999.
13. Ikeda Y. The diagnosis and therapy of ITP. JJPA 19: 146-154, 2004 (in Japanese).
14. Popper H, Schaffner F. Nonsuppurative destructive chronic cholangitis and chronic hepatitis. Prog Liver Dis 13: 336-354, 1970.
15. Kloppel G, Seifert G, Lindner H, Dammermann R, Sack HJ, Berg PA. Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Correlations of liver histology with mitochondrial antibodies of different specificity. Virchows Arch A Pathol Anat Histol 373: 143-160, 1977.
16. Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 113: 884-890, 1997.
17. Czaja AJ. Drug therapy in the management of type 1 autoimmune hepatitis. Drugs 57: 49-68, 1999.
18. Czaja AJ, Carpenter HA, Lindor KD. Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial. Hepatology 30: 1381-1386, 1999.
19. Miyake Y, Iwasaki Y, Takaki A, Kobashi H, Sakaguchi K, Shiratori Y. Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis. Intern Med 46: 1945-1949, 2007.
20. Talwalkar JA, Keach JC, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system. Am J Gastroenterol 97: 1191-1207, 2002.
21. Farias AQ, Goncalves LL, Bittencourt PL, et al. Applicability of the IAIHG scoring system to the diagnosis of antimitochondrial/ anti-M2 seropositive variant form of autoimmune hepatitis. J Gastroenterol Hepatol 21: 887-893, 2006.
22. Chong BH, Ho SJ. Autoimmune thrombocytopenia: review. J Thromb Haemost 3: 1763-1772, 2005.
23. Dixon R, Rosse W, Ebbert L. Quantitative determination of antibody in idiopathic thrombocytopenic purpura. N Engl J Med 292: 230-236, 1975.
24. Panzer S, Penner E, Nelson PJ, Prochazka E, Benda H, Saurugger PN. Identification of the platelet glycoprotein IIb/IIIa complex as a target antigen in primary biliary cirrhosis-associated autoimmune thrombocytopenia. Evidence that platelet-reactive autoantibodies can also bind to the mitochondrial antigen M2. J Autoimmun 3: 473-483, 1990.
25. Arakawa Y, Amaki S, Miyakawa H, et al. PBC-AIH overlap syndrome with concomitant ITP and Hashimoto's disease with positivity for anti-centromere antibody. J Gastroenterol 39: 490-495, 2004.
26. Asaka M, Sugiyama T, Kato M, et al. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Helicobacter 6: 254-261, 2001.
27. Suzuki T, Matsushima M, Masui A, et al. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura- a randomized controlled trial. Am J Gastroenterol 100: 1265-1270, 2005.
28. Suvajdzi N, Stankovi B, Artiko V, et al. Helicobacter pylori eradication can induce platelet recovery in chronic idiopathic thrombocytopenic purpura: prospective cohort study. Platelets 17: 227-230, 2006.
29. Fujimura K, Kuwana M, Kurata Y, et al. Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan. Int J Hematol 81: 162-168, 2005.
30. Abraham S, Begum S, Isenberg D. Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis 63: 123-129, 2004.
31. Ishikawa M, Okada J, Shibuya A, Kondo H. CRST syndrome (calcinosis cutis, Raynaud's phenomenon, sclerodactyly, and telangiectasia) associated with autoimmune hepatitis. Intern Med 34: 6-9, 1995.
32. Marie I, Levesque H, Tranvouez JL, et al. Autoimmune hepatitis and systemic sclerosis: a new overlap syndrome? Rheumatology 40: 102-106, 2001.
33. Steen VD, Medsger TA Jr. Case-control study of cortico-steroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 41: 1613-1619, 1998.